HONG KONG – Chinese drugmakers have gotten a boost in the wake of the Chinese government's announcement to cut the value-added tax (VAT) on treatments for a range of rare diseases, in the country's latest move to overhaul its health care system and expand access to better-quality and cheaper drugs.
HONG KONG – Chinese drugmakers have gotten a boost in the wake of the Chinese government's announcement to cut the value-added tax (VAT) on treatments for a range of rare diseases, in the country's latest move to overhaul its health care system and expand access to better-quality and cheaper drugs.
HONG KONG – Chinese drugmakers' stocks hit their worst slump since 2008 last week on reports of a government pilot program aimed at lowering generic drug prices.
HONG KONG – Chinese drugmakers' stocks hit their worst slump since 2008 last week on reports of a government pilot program aimed at lowering generic drug prices.
HONG KONG – The Indian government reportedly made moves in late October to prevent the rupee from falling further against the U.S. dollar. While the Indian currency is expected to benefit from the proposed plan, local pharmaceutical firms are likely to suffer from a stronger rupee.
HONG KONG – The Indian government reportedly made moves in late October to prevent the rupee from falling further against the U.S. dollar. While the Indian currency is expected to benefit from the proposed plan, local pharmaceutical firms are likely to suffer from a stronger rupee.
HONG KONG – A wave of bad news, not least of which is a faulty vaccines scandal in China, has hit Hong Kong-listed biotechnology stocks hard in 2018. However, on Oct. 31, Innovent Biologics Inc. debuted on the Hong Kong Stock Exchange with a surprising 19 percent price jump, breaking the curse of sharp price drops when the previous three biotech flotations first began trading.
HONG KONG – A wave of bad news, not least of which is a faulty vaccines scandal in China, has hit Hong Kong-listed biotechnology stocks hard in 2018. However, on Oct. 31, Innovent Biologics Inc. debuted on the Hong Kong Stock Exchange with a surprising 19 percent price jump, breaking the curse of sharp price drops when the previous three biotech flotations first began trading.
HONG KONG – China-based Hansoh Pharmaceutical Group Co. Ltd. has filed for an IPO in Hong Kong, making it the 11th biopharma company to seek a listing on the Hong Kong Stock Exchange (HKEX) since May and following Ascentage Pharma Group International's IPO a week earlier.
